NEW YORK (GenomeWeb News) — Enigma Diagnostics yesterday said it has licensed a “broad range” of technologies from the UK’s Defense Science and Technology Laboratory that will give the company “much greater control” over IP “at the heart” of its real-time PCR systems.
 
The worldwide exclusive license covers 25 DSTL patents and patent applications. In particular, the license covers the Pyrostart, ResonSense, and Temperature Control, technologies, which Enigma called “important elements” of its RT-PCR systems.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.